Table 2

Adjusted associations† between different measures of the OP of PM10 and PM2.5, and percentage changes in FENO, lung function and markers in NAL 2 h after exposure

All sitesOutdoor onlyAll sites, adjusted underground
Estimate (%)(95% CI)Estimate (%)(95% CI)Estimate (%)(95% CI)
FENO
 OPAA_PM103.8*(0.8 to 6.8)10.0**(3.5 to 16.4)9.0**(2.9 to 15.0)
 OPAA_PM2.53.6**(1.1 to 6.2)13.6**(7.4 to 19.8)13.1**(7.1 to 19.2)
 OPESR_PM102.4*(0.5 to 4.4)9.2**(3.9 to 14.5)9.2**(4.1 to 14.2)
 OPESR_PM2.52.5*(0.6 to 4.4)10.4**(5.2 to 15.7)10.2**(5.2 to 15.3)
 OPDTT_PM102.2*(0.2 to 4.2)14.8**(6.5 to 23.0)13.9**(6.8 to 21.0)
 OPDTT_PM2.53.6**(1.1 to 6.2)10.8**(4.7 to 17.0)10.9**(5.4 to 16.5)
FVC‡
 OPAA_PM10−0.22(−0.79 to 0.34)−1.17*(−2.35 to 0.00)−0.94(−2.08 to 0.20)
 OPAA_PM2.5−0.12(−0.60 to 0.35)−0.98(−2.17 to 0.21)−0.85(−2.02 to 0.32)
 OPESR_PM10−0.13(−0.50 to 0.23)−1.05*(−2.02 to −0.08)−0.96*(−1.91 to 0.00)
 OPESR_PM2.5−0.07(−0.43 to 0.29)−0.67(−1.67 to 0.33)−0.61(−1.58 to 0.36)
 OPDTT_PM10−0.05(−0.42 to 0.32)−1.50#(−3.03 to 0.02)−0.76(−2.12 to 0.60)
 OPDTT_PM2.50.03(−0.46 to 0.51)−0.09(−1.26 to 1.07)0.05(−1.04 to 1.15)
FEV1
 OPAA_PM10−0.33(−0.86 to 0.20)−1.29*(−2.37 to −0.21)−1.00(−2.08 to 0.07)
 OPAA_PM2.5−0.25(−0.70 to 0.21)−1.17*(−2.31 to −0.04)−1.03(−2.16 to 0.10)
 OPESR_PM10−0.20(−0.54 to 0.14)−1.09*(−1.99 to −0.18)−1.01*(−1.91 to −0.11)
 OPESR_PM2.5−0.19(−0.53 to 0.16)−0.95*(−1.90 to 0.00)−0.96*(−1.89 to −0.02)
 OPDTT_PM10−0.11(−0.46 to 0.24)−1.08(−2.52 to 0.36)−0.63(−1.91 to 0.66)
 OPDTT_PM2.5−0.07(−0.54 to 0.40)−0.15(−1.27 to 0.98)0.01(−1.05 to 1.07)
NAL IL-6§
 OPAA_PM1014.7*(2.3 to 28.7)30.3*(3.6 to 64.0)36.9**(8.3 to 72.9)
 OPAA_PM2.510.7*(1.2 to 21.1)17.8(−2.9 to 42.8)23.3*(0.9 to 50.7)
 OPESR_PM107.9*(0.3 to 16.0)23.5*(2.1 to 48.9)27.8*(4.9 to 55.0)
 OPESR_PM2.56.8(−0.2 to 14.2)10.9(−5.8 to 30.5)13.0(−4.7 to 34.1)
 OPDTT_PM108.8*(1.5 to 16.5)39.2**(14.6 to 69.0)41.5**(17.2 to 70.9)
 OPDTT_PM2.512.4**(3.3 to 22.2)20.0*(1.1 to 42.4)29.0**(9.1 to 52.7)
NAL protein§
 OPAA_PM102.9(−5.6 to 11.4)16.5*(0.7 to 32.4)11.8(−5.7 to 29.2)
 OPAA_PM2.52.2(−4.3 to 8.7)11.8(−1.3 to 24.9)10.4(−4.3 to 25.0)
 OPESR_PM101.2(−4.1 to 6.6)8.9(−4.3 to 22.1)9.0(−5.6 to 23.5)
 OPESR_PM2.51.0(−3.8 to 5.9)6.4(−4.8 to 17.5)5.9(−6.5 to 18.2)
 OPDTT_PM101.2(−3.8 to 6.2)11.4(−2.7 to 25.4)9.6(−4.8 to 24.0)
 OPDTT_PM2.51.5(−4.7 to 7.6)6.1(−5.7 to 17.9)5.4(−7.1 to 17.8)
NAL lactoferrin§
 OPAA_PM1020.9*(3.6 to 41.0)24.7(−6.5 to 66.5)25.3(−8.6 to 71.7)
 OPAA_PM2.514.0*(1.2 to 28.5)13.1(−11.6 to 44.6)13.8(−13.1 to 48.9)
 OPESR_PM1011.2*(0.9 to 22.6)14.9(−9.4 to 45.8)12.0(−14.0 to 45.8)
 OPESR_PM2.510.5*(1.1 to 20.7)15.2(−6.2 to 41.4)12.4(−10.3 to 40.8)
 OPDTT_PM109.6*(0.0 to 20.0)8.0(−16.4 to 39.6)4.8(−19.4 to 36.3)
 OPDTT_PM2.510.1(−1.6 to 23.3)−0.2(−19.8 to 24.1)0.6(−19.9 to 26.4)
  • #p<0.10; *p<0.05; **p<0.01.

  • †Expressed as percentage increase per change in IQR in the log-transformed concentrations at the outdoor sites: 0.72 and 0.71 for OPDTT of PM2.5 and PM10; 1.14 and 1.27 for OPESR of PM2.5 and PM10; 1.15 and 1.51 for OPAA of PM2.5 and PM10, implying a p75/p25 ratio ranging from 2.0 (OPDTT-PM10) to 4.5 (OPAA-PM10).

  • ‡Adjusted for temperature, relative humidity, season, pollen counts and respiratory infections (as in ref 13).

  • §Adjusted for temperature, relative humidity, season (as in ref 14) and endotoxin.

  • NAL, nasal lavage; OP, oxidative potential; PM, particulate matter; NAL, nasal lavage.